drugIndia
Cart
Gliprip-MV2 Tablet PR

Gliprip-MV2 Tablet PR

Glimepiride (2mg) + Voglibose (0.2mg) + Metformin (500mg)

Suraksha Pharma Pvt Ltd
Glaucoma
87.80109.7520% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 50%
Best Alternative100% Match

Ozomet-VG2 Tablet SR

Ozone Pharmaceuticals Ltd

Voglibose 0.2mg
Ozomet-VG2 Tablet SR

Pack Size

1 units

Price

43.8420% off
Ozomet-VG2 Tablet SR is 100% same as Gliprip-MV2 Tablet PR
Better ValueSame QualitySame Effectiveness

Save ₹44

that's 50% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 2mg
  3. Metformin 500mg
Buy Now
87.8020% OFF
109.75

About This Medicine

Product description & overview

Gliprip-MV2 Tablet PR

Gliprip-MV2 Tablet PR, a once-daily combination medication, offers effective glycemic control for patients with type 2 diabetes. It contains a precise blend of Glimepiride (2mg), Metformin (500mg), and Voglibose (0.2mg).

This synergistic formulation provides the following benefits:

* Glimepiride: Promotes insulin secretion, directly enhancing blood sugar reduction.
* Metformin: Reduces glucose production in the liver and enhances cellular glucose uptake.
* Voglibose: A specific α-glucosidase inhibitor that slows down the digestion and absorption of carbohydrates, further lowering postprandial blood glucose levels.

Gliprip-MV2 Tablet PR is intended for adults with type 2 diabetes who need help managing their blood sugar. It's formulated for convenient once-daily administration, offering increased patient compliance and a consistent approach to treatment.

Note: This medication should only be taken under the supervision of a qualified healthcare professional. Consult your doctor or pharmacist before starting any new medication.

Active composition

Glimepiride 2 mg

+2 more active ingredients

About Glimepiride

Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.

How It Works

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Medicine Strength
2 mg

All Active Ingredients

Glimepiride2 mg
Voglibose0.2 mg
Metformin500 mg

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Gliprip-MV2 Tablet PR.

High Risk

Pregnancy

Gliprip-MV2 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Gliprip-MV2 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Gliprip-MV2 Tablet PR may be needed. Please consult your doctor. Gliprip-MV2 Tablet PR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Gliprip-MV2 Tablet PR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Gliprip-MV2 Tablet PR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Gliprip-MV2 Tablet PR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Gliprip-MV2 Tablet PR

Products matching your search